Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14779
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRadchatawedchakoon W.
dc.contributor.authorWatanapokasin R.
dc.contributor.authorKrajarng A.
dc.contributor.authorYingyongnarongkul B.-e.
dc.date.accessioned2021-04-05T03:37:11Z-
dc.date.available2021-04-05T03:37:11Z-
dc.date.issued2010
dc.identifier.issn9680896
dc.identifier.other2-s2.0-72149112492
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14779-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-72149112492&doi=10.1016%2fj.bmc.2009.10.057&partnerID=40&md5=f1a09ff986602cf0a9e30304b768f92e
dc.description.abstractTwenty-four asymmetric divalent head group cholesterol-based cationic lipids were designed and synthesized by parallel solid phase chemistry. These asymmetric head groups composed of amino functionality together with trimethylamino, di(2-hydroxyethyl)amino or guanidinyl groups. Spacers between cationic heads and linker were both equal and unequal in length. These lipids were subjected to evaluation for DNA binding affinities by gel retardation assay and were screened for their transfection efficiency on HEK293 cells. Cationic lipids with equal chain length exhibited high transfection efficiency when polar part contained asymmetric polar heads. In contrast, lipids with unequal chain length exhibited high transfection efficiency when polar part contained symmetric heads. According to the optimal formulation, seven lipids exhibited higher transfection efficiency than the commercially available transfection agents, Effectene™, DOTAP and DC-Chol, to deliver DNA into PC3 human prostate adenocarcinoma cells. 3β-[N-(N′-Guanidinyl)-2′-aminoethyl)-N-(2-aminoethyl)ca rbamoyl] cholesterol (5) bearing amino and guanidinyl polar heads exhibited highest transfection efficiency with minimal toxicity. The morphology of active liposomes was observed by transmission electron microscopy (TEM) and size of liposomes were around 200-700 nm. © 2009 Elsevier Ltd. All rights reserved.
dc.subject3b [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n (2' aminoethyl) n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n (2' aminoethyl) n [n glycine[n (3 aminopropyl) amide]]carbamoyl]cholesterol
dc.subject3beta [n (3' aminopropyl) n [n glycine[n (2 aminoethyl) amide]]carbamoyl]cholesterol
dc.subject3beta [n (3' aminopropyl) n [n glycine[n (3 aminopropyl) amide]]carbamoyl]cholesterol
dc.subject3beta [n (n' guanidinyl 2' aminoethyl) n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n (n' guanidinyl 2' aminoethyl) n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n (n' guanidinyl 3' aminopropyl) n [n glycine [n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n (n' guanidinyl 3' aminopropyl) n [n glycine[n (2 aminoethyl)amide]] carbamoyl]cholesterol
dc.subject3beta [n (n' guanidinyl) 2' aminoethyl n (2 aminoethyl)carbamoyl]cholesterol
dc.subject3beta [n (n',n' di(2'' hydroxyethyl) 3' aminopropyl) n (3 aminopropyl)carbamoyl]cholesterol
dc.subject3beta [n [(n' guanidinyl) 2' aminoethyl] n (2 aminoethyl) carbamoyl]cholesterol
dc.subject3beta [n [(n' guanidinyl) 3' aminopropyl] n (3 aminoproyl)carbamoyl]cholesterol
dc.subject3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n (2 amino ethyl)carbamoyl]cholesterol
dc.subject3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n (3 aminopropyl)carbamoyl]cholesterol
dc.subject3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n [n glycine [n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n [n glycine [n (3 aminopropyl)amide]]carbamoyl] cholesterol
dc.subject3beta [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n (2 aminoethyl)carbamoyl]cholesterol
dc.subject3beta [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n [n',n' di(2'' hydroxyethyl) 3' aminopropyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n [n',n' di(2'' hydroxyethyl) 3' aminopropyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject3beta [n,n (2,2' diaminoethyl)carbamoyl]cholesterol
dc.subject3beta [n,n (3,3' diaminopropyl)carbamoyl]cholesterol
dc.subjectcholesterol derivative
dc.subjectunclassified drug
dc.subjectarticle
dc.subjectbinding affinity
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcontrolled study
dc.subjectDNA binding
dc.subjectDNA transfection
dc.subjectdrug design
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectgene targeting
dc.subjecthuman
dc.subjecthuman cell
dc.subjectprostate adenocarcinoma
dc.subjectproton nuclear magnetic resonance
dc.subjectsolid phase synthesis
dc.subjecttransmission electron microscopy
dc.subjectBinding Sites
dc.subjectCations
dc.subjectCell Line
dc.subjectCell Line, Tumor
dc.subjectCholesterol
dc.subjectDNA
dc.subjectHumans
dc.subjectLipids
dc.subjectLiposomes
dc.subjectPhosphatidylethanolamines
dc.subjectSerum
dc.subjectTransfection
dc.titleSolid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationBioorganic and Medicinal Chemistry. Vol 18, No.1 (2010), p.330-342
dc.identifier.doi10.1016/j.bmc.2009.10.057
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.